Articles tagged with: Autologous Stem Cell Transplant
Opinion»

It’s been 37 long, hard days away from home for my salvage transplant. The good news: I’m home early!
I left last week facing a very difficult decision: Should I take my specialist’s advice and move forward with a second, tandem, stem cell transplant?
My doctor felt if the first one didn’t work, well, skip the second transplant. But if the one I just had got most, or all, of my myeloma, crush it with a second transplant.
“Don’t make a decision now,” he told me and my wife Pattie at our …
News»

The 51st annual meeting of the American Society of Clinical Oncology (ASCO) started earlier today, May 29, and will go through June 2 in Chicago.
Approximately 30,000 physicians and researchers from all over the world are expected to attend the five-day meeting to discuss current research in cancer treatment and care.
During the meeting, there will be presentations about all types of cancer, including many presentations focused specifically on multiple myeloma. In fact, more than 90 myeloma-related studies are scheduled to be presented, in one form or another, in connection with the …
Opinion»

I’m fond of saying, “I still have a number of myeloma therapy options, but none of them are good.” The last part is a reflection of investigational work I’ve done speaking with a number of myeloma experts I know.
For two months, I’ve promised to share which direction my lovely wife, Pattie, and I have decided to go in terms of my next treatment. After six months of pros and cons lists, conversations with readers, family, friends, and other myeloma survivors, we’ve made a decision. We were emboldened after shifting through piles of therapy and …
News»

A recently published study may change the goals many myeloma specialists use to make treatment decisions for newly diagnosed myeloma patients planning on having a stem cell transplant.
The study also has potentially broader implications. Indeed, it may influence ongoing debate on a fundamental controversy about how multiple myeloma, in general, should be treated.
The authors of the new study looked at data for 539 myeloma patients who failed to achieve even a partial response to their initial (induction) treatment regimen after diagnosis.
After their initial treatment failed, some of the 539 patients …
Opinion»

In many of my previous columns, I have stipulated that I am very fortunate with what I have experienced so far with multiple myeloma.
My condition is far less serious than that of most of the other Beacon columnists and probably the vast majority of my readers. Every form of treatment I have received so far – radiation, induction therapy, and autologous stem cell transplantation – has been successful. Modern medicine had done its part for me.
Unfortunately, I have come to the conclusion that I have not done my part to …
News»

This past Sunday was the second day of the American Society of Hematology’s (ASH) annual meeting, which was held in San Francisco.
As on the first day of the meeting, myeloma-related presentations once again took place during several sessions throughout the day.
A myeloma-related education session held the first day of the conference was repeated once again on Sunday morning.
While the education session was being held, a separate “scientific symposium” with two oral presentations took place in parallel. The session focused on a novel immunotherapeutic approach to treating cancer known as …
News»

This year’s meeting of the American Society of Hematology (ASH) began yesterday morning in San Francisco.
Myeloma-related presentations were made during several sessions throughout the day.
The day started out with a session designed to better educate physicians about multiple myeloma and how to treat the disease.
Two sessions of oral presentations devoted solely to multiple myeloma ran simultaneously in the middle of the day. One of the sessions focused on the biology of the disease. The other one included presentations on new myeloma therapies for both newly diagnosed and relapsed and …